Introduction
Two recent reports have related effects of corticosteroids in fetal tissues to the enzyme which increases corticosterone by reduction of 11-dehydrocorticosterone. The latter is abundant in fetal tissues until late gestation, and reduction to the 116-OH configuration increases the amount of active hormone at the expense of the inactive metabolite. Inhibition of this reaction prevented maturation of fetal rat lunq, as measured by phospholipid synthesis (5) . Rising reductase activity in fetal mouse liver (3) coincided with a decrease in the dehydrogenation reaction in mouse brain, which was considered responsible for a marked decrease in the rate of incorporation of leucine, uridine and thymidine into fetal mouse brain (7) . This communication describes similar effects in mouse placenta, indicating an action of corticosteroids on this tissue.
Materials and Methods
The mice used were of the UBC Swiss strain, raised at the Zoology Department Vivarium at this University. The timing of pregnancies, the preparation and incubation of tissues and measurement of incorporation of le~cine-'~c(u), uridine-53~ and thymidine methyl-'H into the acid-insoluble components of tissues have been described earlier (7) . The preparation of ll-dehydrocorticosterone-4-"C and incubation of it and corticosterone-4-''c with tissues and the preparation of autoradiograms has also been described therein. The assay for ornithine decarboxylase activity by collection of ' '~0~ liberated from ornithine-l-Iuc has been described elsewhere (6) .
Results
The reduction of 11-dehydrocorticosterone to corticosterone in fetal mouse liver and placenta on gestational days 14 and 17 is illustrated in Fig. 1 . In similar experiments the dehydrogenation of corticosterone was also followed in these tissues. The ratio of reductase/dehydrogenase activity increased in liver from 0.1 to 7 between days 14 and 17. In placenta reductase activity remained high at all times, the ratio was over 4. Table 1 gives the values for the incorporation of radioactive substrates into placenta on gestational days 14, 16 and 19. In all cases there was a significant decrease in the rate of incorporation after day 14, when changes in liver reductase activity began. This continued for several days with the greatest change between days 14 and 16. The values for leucine, uridine and thymidine fell by 61, 30 and 72%. respectively, of those on day 14. Ornithine decarboxylase activity followed a similar pattern (Table l) , declining by 75% on day 19. That these events can be attributed to the steroid is indicated by the fact that injection of dexamethasone on day 13.5 resulted in values on day 14 for all parameters which were reduced to a level found normally on days 15 to 18 (Table 1) .
Microscopic examination of sections from treated placentas did not reveal any significant differences from controls. Discussion Until gestational day 14, 11-dehydrocorticosterone in fetoplacental tissues predominates over the active hormone by at least eightfold. This was attributed in earlier work (1) to dehydrogenase activity in fetal tissues and placenta. Subsequently, however, using double isotope labelling of substrates to ascertain both dehydrogenase and reductase activities simultaneously, it was found that the ratio of reduction/dehydrogenation in placenta remains around 4 ( Fig. l) , while the brain is the major site of dehydrogenation (3, 7) . Conceivably the placenta functions to reduce the metabolite formed in fetal tissues before returning it to the maternal compartment. By contrast, reductase activity in fetal liver increased greatly, changing the ratio of reduction/dehydrogenation from 0.1 to 7 between days 14 and 17. It is Drobablv this activitv which is the maior factor in raisino ~ -corticosterone concencracions In che fetal clrculacion and In blood entering che placenca from the fetus (3).
The presence of corticosteroid receptors in cytosol and nuclei of placenta has been reported (a), suggesting that this is a "target" organ. The induction of specific biochemical events in placenta by corticosteroids. however, does not appear to have been reported previously. The decrease in the incorporation of leucine, uridine and thymidine observed here (Table 1) is similar to that observed in fetal brain (7) . also attributed to an increase in active corticosteroid. In both instances these events could be produced prematurely by the injection of a potent synthetic corticoid, dexamethasone. The synthetic compound was used in these experiments because it escapes to a large extent the metabolic regulation which limits the passage of hormone from mother to fetus, with the result that a more effective dose reaches the fetus (9). It was found that, 16 hours after injection, 6% of the dexamethasone remained in the maternal circulation. After 15 minutes, there was estimated (9) to be 60 ng/ mg fetal protein. Since the receptor site concentration in brain (7) and in placenta (8) is less than 1 pmole/mg protein, it seems likely that receptors were saturated and the effect of the dexamethasone maximal. While there was variation in the response, it should be pointed out that the stimulus here is being applied 1 to 2 days earlier than the rise in corticosteroid which occurs in the normal course of development, (3, Fig. 1 ) and this might modify the magnitude of the response in a tissue. In any case, all treated fetuses responded, with the values obtained being in the range normally observed between gestational days 15 and 18.
The decrease in ornithine decarboxylase activity parallelled that of thymidine incorporation in both placenta (Table 1 ) and in fetal brain (7) . Ornithine decarboxylase is an indicator of change in metabolic or proliferative activity of tissues induced by hormones (6) . A similar decline in thymidine kinase activity at this stage has been reported in rat placenta (6) . These data suggest a decrease in the rate of several biosynthetic processes in fetal tissues and placenta of which DNA is the most affected. Corticosteroid-induced maturation of fetal rabbit lunq was accompanied by decreased growth and decreased cell division both & vivo (2) and in vitro (4) . Normal maturation could be inhibited bya steroid, 11-keto-progesterone, which inhibited 116-reductase activity in fetal rat lung (5). These events appear to be part of a spectrum of effects of corticosteroids on fetal growth, mediated primarily by changes in the activity of the enzyme, llghydroxyster0id:NADP oxidoreductase, which might function in different tissues somewhat independently. Table 1 . Ornithine decarboxylase activity and the in vitro incorporation of" C-leucine, 'H-uridine Z d F thymidine into mouse placenta.
Dexamethasone, 200 ug, was injected subcutaneously 16 hr earlier.
Ornithine decarboxylase activity was assayed by incubating the 20,000 x g supernatant of placenta with 50 nCi 'c-D,Lornithine for 30 min, following which ''~0~ was trapped in hyamine. "c-leucine, 0.14 uCi, %-uridine, 0.46 uCi and 'Hthymidine, 0.46 uCi, were incubated in 1 ml bicarbonate buffer pH 7.4 for 1 hr. The tissue was then homogenized, an aliquot removed for protein determination, and 0.1 vol 30% TCA was added. Liver from fetuses of a litter, or 2 placentas were minced finely and incubated in 1 ml buffer pH 7.4 with 5 nCi "c-11-dehydrocorticosterone for 15 min. The mixture was extracted with CH2C1, which was evaporated and spotted onto silica gel TLC sheets, developed in first, hexane:ethyl acetate (4:l) and secondly, toluene:chloroform:methanol:water (120:60:20:1: v:v). A: 11-dehydrocorticosterone; B: corticosterone. 1, fetal liver, day 14; 2 fetal liver day 17; 3, placenta, day 14; 4, placenta day 17. Note the increase in the size of the B zone in liver on gestational day 17. Ornithine decarboxylase, pm0leS Co2/mq protein
